Is a complete ORMP research report available?

No complete published report is available for Oramed Pharmaceuticals Inc. (ORMP) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Oramed Pharmaceuticals Inc. (ORMP)

NASDAQ: ORMP · USD

$4.13

-0.03 (-0.7%)· Recorded snapshot

Market cap	171.8M
Net income (ttm)	174.1M
EPS (ttm)	$4.15
Shares out	41.6M
P/E (trailing)	1.0x
Dividend	$0.25 (6.03%)
Volume	40,152
Beta	1.28

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): 174.1M
EPS (ttm): $4.15
P/E (trailing): 1.0x
Market cap: 171.8M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	احتفاظ

Metric	Value
Amount currency	USD
CIK code	0001176309
Company name	Oramed Pharmaceuticals Inc.
Country	United States
Country code	US
CUSIP number	68403P203
Earnings date	2026-11-12
Earnings time	amc
Employees	4
Enterprise value	$100.1M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2002
In index	RUSSELL2000
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	US68403P2039
Last 10-K release date	2026-03-26
Last earnings date	2026-08-10
Last refreshed	2026-10-28
Last stock split date	2013-01-23
Last stock split type	Reverse
Market cap	$171.8M
Market cap category	Micro-Cap
Next earnings date	2026-11-12
Options	Yes
Price	$4.13
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	ORMP
U.S. state	New York
Website	https://oramed.com

Metric

Value

Amount currency

USD

CIK code

0001176309

Company name

Oramed Pharmaceuticals Inc.

Country

United States

Country code

CUSIP number

68403P203

Earnings date

2026-11-12

Earnings time

amc

Employees

Enterprise value

$100.1M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2002

In index

RUSSELL2000

Industry

Biotechnology

Is primary listing

Yes

Is SPAC

ISIN number

US68403P2039

Last 10-K release date

2026-03-26

Last earnings date

2026-08-10

Last refreshed

2026-10-28

Last stock split date

2013-01-23

Last stock split type

Reverse

Market cap

$171.8M

Market cap category

Micro-Cap

Next earnings date

2026-11-12

Options

Yes

Price

$4.13

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

ORMP

U.S. state

New York

Website

https://oramed.com

Metric	Value
Average P/E ratio (3Y)	7.76x
Earnings yield	100.43%
EV/Earnings	0.57x
FCF / EV yield	-5.21%
FCF yield	-3.04%
Graham number	26.7794
Graham upside	548.41%
P/B ratio	0.54x
P/E ratio	1x
Price / tangible book value	0.54x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Average P/E ratio (3Y)

7.76x

Earnings yield

100.43%

EV/Earnings

0.57x

FCF / EV yield

-5.21%

FCF yield

-3.04%

Graham number

26.7794

Graham upside

548.41%

P/B ratio

0.54x

P/E ratio

Price / tangible book value

0.54x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
Effective tax rate	20.62%
Profit per employee	$43.5M
Profitable quarters	5
Profitable years	1
ROA	-3.42%
ROCE	-4.05%
ROE	74.24%
ROIC	-5.23%
ROIC (5Y)	-157%

Metric

Value

Effective tax rate

20.62%

Profit per employee

$43.5M

Profitable quarters

Profitable years

ROA

-3.42%

ROCE

-4.05%

ROE

74.24%

ROIC

-5.23%

ROIC (5Y)

-157%

Metric	Value
EPS growth (Q)	493.55%
EPS growth (QoQ)	102.2%
EPS growth quarters	5
EPS growth years	1
Net income growth (Q)	488.17%
Net income growth (QoQ)	104.01%
Net income growth quarters	5
Net income growth years	1
Revenue growth years	0

Metric

Value

EPS growth (Q)

493.55%

EPS growth (QoQ)

102.2%

EPS growth quarters

EPS growth years

Net income growth (Q)

488.17%

Net income growth (QoQ)

104.01%

Net income growth quarters

Net income growth years

Revenue growth years

Metric	Value
Capital expenditures	$-9,000
Depreciation and amortization	$122,000
EBIT	$-14.5M
EBITDA	$-14.4M
EPS	$4.15
FCF per share	$-0.13
Financing cash flow	$-16.7M
Free cash flow	$-5.2M
Free cash flow minus SBC	$-11.3M
Income taxes	$45.4M
Investing cash flow	$21.5M
Net cash flow	$-552,000
Net income	$174.1M
Operating cash flow minus SBC	$-11.3M
Operating income	$-14.5M
Stock-based compensation	$6.1M

Metric

Value

Capital expenditures

$-9,000

Depreciation and amortization

$122,000

EBIT

$-14.5M

EBITDA

$-14.4M

EPS

$4.15

FCF per share

$-0.13

Financing cash flow

$-16.7M

Free cash flow

$-5.2M

Free cash flow minus SBC

$-11.3M

Income taxes

$45.4M

Investing cash flow

$21.5M

Net cash flow

$-552,000

Net income

$174.1M

Operating cash flow minus SBC

$-11.3M

Operating income

$-14.5M

Stock-based compensation

$6.1M

Metric	Value
Altman Z-Score	1.39
Book value per share	$7.68
Debt / equity	0
Long-term assets	$316.2M
Long-term liabilities	$41.4M
Net cash (debt)	$71.7M
Net cash / market cap	41.76%
Net cash growth	-26.06%
Net debt / equity	-0.23
Piotroski F-Score	1
Property, plant and equipment	$1.1M
Shareholders' equity	$317.5M
Tangible book value	$317.5M
Tangible book value per share	$7.68
Total assets	$369.6M
Total cash	$50.6M
Total debt	$733,000
Total liabilities	$52.2M
WACC	11.22%

Metric

Value

Altman Z-Score

1.39

Book value per share

$7.68

Debt / equity

Long-term assets

$316.2M

Long-term liabilities

$41.4M

Net cash (debt)

$71.7M

Net cash / market cap

41.76%

Net cash growth

-26.06%

Net debt / equity

-0.23

Piotroski F-Score

Property, plant and equipment

$1.1M

Shareholders' equity

$317.5M

Tangible book value

$317.5M

Tangible book value per share

$7.68

Total assets

$369.6M

Total cash

$50.6M

Total debt

$733,000

Total liabilities

$52.2M

WACC

11.22%

Metric	Value
Current assets	$53.4M
Current liabilities	$10.7M
Current ratio	4.98
Net working capital	$-7.7M
Quick ratio	4.85
Working capital	$42.7M

Metric

Value

Current assets

$53.4M

Current liabilities

$10.7M

Current ratio

4.98

Net working capital

$-7.7M

Quick ratio

4.85

Working capital

$42.7M

Metric	Value
Buyback yield / dilution	-2.31%
Dividend growth	0%
Dividend growth years	0
Dividend payment date	2026-01-26
Dividend payment years	1
Dividend per share	$0.25
Dividend yield	6.03%
Ex-dividend date	2026-01-16
Last dividend	$0.25
Payout ratio	6.03%
Shareholder yield	3.75%

Metric

Value

Buyback yield / dilution

-2.31%

Dividend growth

Dividend growth years

Dividend payment date

2026-01-26

Dividend payment years

Dividend per share

$0.25

Dividend yield

6.03%

Ex-dividend date

2026-01-16

Last dividend

$0.25

Payout ratio

6.03%

Shareholder yield

3.75%

Metric	Value
10Y price change	-38.65%
10Y return CAGR	-4.1%
10Y total return	-34.19%
150-day SMA	$4.23
15Y price change	-4.28%
15Y return CAGR	0.18%
15Y total return	2.67%
1D price change	-0.72%
1M price change	-12.58%
1M total return	-12.58%
1W price change	-0.36%
1W total return	-0.36%
1Y price change	74.47%
1Y return CAGR	87.23%
1Y total return	87.15%
20-day SMA	$4.23
200-day SMA	$4.03
20Y price change	-55.25%
20Y return CAGR	-3.6%
20Y total return	-52%
3M price change	-0.6%
3M total return	-0.6%
3Y price change	123.51%
3Y return CAGR	33.83%
3Y total return	139.76%
50-day SMA	$4.59
50-day SMA vs 200-day SMA	50over200
52-week high	$5.47
52-week high date	2026-08-27
52-week low	$2.09
52-week low date	2025-11-07
5Y price change	-82%
5Y return CAGR	-28.03%
5Y total return	-80.69%
6M price change	0.61%
6M total return	0.61%
All-time high	$31.73
All-time high date	2014-01-13
All-time low	$0.15
All-time low date	2004-03-19
Average true range (ATR)	$0.15
Average volume	133.7K
Beta (1Y)	0.8
Beta (2Y)	0.45
Beta (5Y)	1.28
Change from 52-week high	-24.5%
Change from 52-week low	97.61%
Change from all-time high	-86.97%
Change from all-time low	2,741.92%
Change from open	0.73%
Day's gap	-1.44%
Dollar volume	$165,828
High price	$4.15
Low price	$4.10
Monthly RSI	54.95
Open price	$4.10
Position in 52-week range	60%
Premarket change	-1.2%
Premarket close	$4.16
Premarket price	$4.11
Previous close	$4.16
Price vs 150-day SMA	-2.18%
Price vs 20-day SMA	-2.25%
Price vs 200-day SMA	2.73%
Price vs 50-day SMA	-9.97%
Relative volume	0.3
RSI	39.08
Sharpe ratio	1.37
Sharpe ratio (3Y)	0.71
Sharpe ratio (5Y)	0.02
Sortino ratio	2.44
Sortino ratio (3Y)	1.3
Sortino ratio (5Y)	0.1
Volume	40.2K
Weekly RSI	48.93
YTD price change	45.09%
YTD total return	55.63%

Metric

Value

10Y price change

-38.65%

10Y return CAGR

-4.1%

10Y total return

-34.19%

150-day SMA

$4.23

15Y price change

-4.28%

15Y return CAGR

0.18%

15Y total return

2.67%

1D price change

-0.72%

1M price change

-12.58%

1M total return

-12.58%

1W price change

-0.36%

1W total return

-0.36%

1Y price change

74.47%

1Y return CAGR

87.23%

1Y total return

87.15%

20-day SMA

$4.23

200-day SMA

$4.03

20Y price change

-55.25%

20Y return CAGR

-3.6%

20Y total return

-52%

3M price change

-0.6%

3M total return

-0.6%

3Y price change

123.51%

3Y return CAGR

33.83%

3Y total return

139.76%

50-day SMA

$4.59

50-day SMA vs 200-day SMA

50over200

52-week high

$5.47

52-week high date

2026-08-27

52-week low

$2.09

52-week low date

2025-11-07

5Y price change

-82%

5Y return CAGR

-28.03%

5Y total return

-80.69%

6M price change

0.61%

6M total return

0.61%

All-time high

$31.73

All-time high date

2014-01-13

All-time low

$0.15

All-time low date

2004-03-19

Average true range (ATR)

$0.15

Average volume

133.7K

Beta (1Y)

0.8

Beta (2Y)

0.45

Beta (5Y)

1.28

Change from 52-week high

-24.5%

Change from 52-week low

97.61%

Change from all-time high

-86.97%

Change from all-time low

2,741.92%

Change from open

0.73%

Day's gap

-1.44%

Dollar volume

$165,828

High price

$4.15

Low price

$4.10

Monthly RSI

54.95

Open price

$4.10

Position in 52-week range

60%

Premarket change

-1.2%

Premarket close

$4.16

Premarket price

$4.11

Previous close

$4.16

Price vs 150-day SMA

-2.18%

Price vs 20-day SMA

-2.25%

Price vs 200-day SMA

2.73%

Price vs 50-day SMA

-9.97%

Relative volume

0.3

RSI

39.08

Sharpe ratio

1.37

Sharpe ratio (3Y)

0.71

Sharpe ratio (5Y)

0.02

Sortino ratio

2.44

Sortino ratio (3Y)

1.3

Sortino ratio (5Y)

0.1

Volume

40.2K

Weekly RSI

48.93

YTD price change

45.09%

YTD total return

55.63%

Metric	Value
Float	29.8M
Float percentage	71.71%
Shares change (QoQ)	1.27%
Shares change (YoY)	2.31%
Shares held by insiders	22.25%
Shares held by institutions	34.74%
Shares outstanding	41.6M
Short % of float	4.81%
Short % of shares	3.45%
Short ratio	7.5 days

Metric

Value

Float

29.8M

Float percentage

71.71%

Shares change (QoQ)

1.27%

Shares change (YoY)

2.31%

Shares held by insiders

22.25%

Shares held by institutions

34.74%

Shares outstanding

41.6M

Short % of float

4.81%

Short % of shares

3.45%

Short ratio

7.5 days

Oramed Pharmaceuticals Inc. (ORMP)

Price

Financial snapshot

Fair-value bridge

Latest news · ORMP

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ORMP indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ORMP

Frequently asked questions